71. Idiopathic osteonecrosis of the femoral head Clinical trials / Disease details
Clinical trials : 2 / Drugs : 3 - (DrugBank : 3) / Drug target genes : 3 - Drug target pathways : 7
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JPRN-UMIN000032412 | 2016/08/21 | 27/04/2018 | Multicenter clinical trial: treatment effect of lansoprazole on non-traumatic osteonecrosis of the femoral head | Multicenter clinical trial: treatment effect of lansoprazole on non-traumatic osteonecrosis of the femoral head - Clinical trial for treatment effect of non-traumatic osteonecrosis of the femoral head | idiopathic osteonecrosis of the femoral head | Lansoprazole 30mg orally once a day for one year No administration | Sapporo Medical University Hospital | NULL | Complete: follow-up complete | 18years-old | 75years-old | Male and Female | 100 | Phase 2 | Japan |
| 2 | JPRN-UMIN000009610 | 2012/12/26 | 26/12/2012 | Clinical study for reducing the risk of progress of idiopathic osteonecrosis of the femoral head (ION) by teriparatide treatment | Clinical study for reducing the risk of progress of idiopathic osteonecrosis of the femoral head (ION) by teriparatide treatment - Risk reduction of progress of ION | idiopathic osteonecrosis of the femoral head | Teriparatide Acetate Normal treatment | Asahikawa Medical University | NULL | Complete: follow-up complete | 20years-old | Not applicable | Male and Female | 50 | Not selected | Japan |